Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 in Antiphospholipid Syndrome
NCT02218476Unknown
- Sponsor
- Maimónides Institute of Biomedical Research of Córdoba
- Start
- Sep 2013
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of coenzyme q10 in antiphospholipid syndrome (APS) (2 arms), sponsored by Maimónides Institute of Biomedical Research of Córdoba. Primary endpoint: Change in endothelial function in vivo at 12 weeks. Status: unknown.
02
Drugs
coenzyme q10
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on NCT02218476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02218476.